<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig2">
 <label>Fig. 2</label>
 <caption>
  <p>Currently known clinical and laboratory biomarkers of severity to predict disease progression, combining with timely antiviral, anti-inflammatory, and anticoagulation intervention to optimize outcome. 
   <italic>CHD</italic> chronic heart disease, 
   <italic>CLD</italic> chronic lung disease, 
   <italic>CKD</italic> chronic kidney disease, 
   <italic>DOACS</italic> direct oral anticoagulants, 
   <italic>FDPs</italic> fibrinogen degradation products, 
   <italic>HTN</italic> hypertension, 
   <italic>IFN</italic> interferon, 
   <italic>JAK</italic> Janus kinase, 
   <italic>LDH</italic> lactate dehydrogenase, 
   <italic>LMWH</italic> low molecular weight heparin, 
   <italic>NSAIDS</italic> non-steroidal anti-inflammatory drugs, 
   <italic>PT</italic> prothrombin time, 
   <italic>TNF</italic> tumor necrosis factor, 
   <italic>VW Ag</italic> Von Willebrand antigen
  </p>
 </caption>
 <graphic xlink:href="41030_2020_126_Fig2_HTML" id="MO2" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
